Table 5.

Correlation analysis between omentin-1 and NGAL and clinicopathological data of all cases under study.

Parameter	Spearman rho∗	Omentin-1	NGAL
Age	p	Insignificant (p > 0.05)	Insignificant (p > 0.05)
	r
Tumor size	p	Significant (p < 0.001)	Significant (p = 0.001)
	r	0.480	0.401
Lymph node	p	Significant (p = 0.001)	Significant (p = 0.01)
	r	0.425	0.331
Metastasis	p	Significant (p < 0.001)	Significant (p < 0.001)
	r	0.780	0.653
Tumor grade	p	Insignificant (p > 0.05)	Insignificant (p > 0.05)
	r
Estrogen receptor (ER)	p	Insignificant (p > 0.05)	Insignificant (p > 0.05)
	r
Progesterone receptor (PR)	p	Insignificant (p > 0.05)	Insignificant (p > 0.05)
	r
HER2neu	p	Insignificant (p > 0.05)	Insignificant (p > 0.05)
	r
	r	0.664	0.646
Omentin-1	p	—	Significant (p < 0.001)
	r		0.805
NGAL	p	Significant (p < 0.001)	—
	r	0.805